Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis

Owens, 1995, Regulation of differentiation of vascular smooth muscle cells, Physiol. Rev., 75, 487, 10.1152/physrev.1995.75.3.487

Watkins, 2006, Genetic susceptibility to coronary artery disease: from promise to progress, Nat. Rev. Genet., 7, 163, 10.1038/nrg1805

Owens, 2004, Molecular regulation of vascular smooth muscle cell differentiation in development and disease, Physiol. Rev., 84, 767, 10.1152/physrev.00041.2003

Libby, 1997, Molecular determinants of atherosclerotic plaque vulnerability, Ann. N. Y. Acad. Sci., 811, 134, 10.1111/j.1749-6632.1997.tb51996.x

Davies, 1994, Lipid and cellular constituents of unstable human aortic plaques, Basic Res. Cardiol., 89, 33

Gorenne, 2006, Vascular smooth muscle cell senescence in atherosclerosis, Cardiovasc. Res., 72, 9, 10.1016/j.cardiores.2006.06.004

Hiltunen, 2002, DNA hypomethylation and methyltransferase expression in atherosclerotic lesions, Vasc. Med., 7, 5, 10.1191/1358863x02vm418oa

Ross, 1984, Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery, Am. J. Pathol., 114, 79

Ying, 2000, Methylation of the estrogen receptor-alpha gene promoter is selectively increased in proliferating human aortic smooth muscle cells, Cardiovasc. Res., 46, 172, 10.1016/S0008-6363(00)00004-3

Kim, 2007, Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence, Biochim. Biophys. Acta, 1772, 72, 10.1016/j.bbadis.2006.10.004

Matthews, 2006, Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress, Circ. Res., 99, 156, 10.1161/01.RES.0000233315.38086.bc

Calvanese, 2009, The role of epigenetics in aging and age-related diseases, Ageing Res. Rev., 8, 268, 10.1016/j.arr.2009.03.004

Fraga, 2007, Epigenetics and aging: the targets and the marks, Trends Genet., 23, 413, 10.1016/j.tig.2007.05.008

Kahn, 2009, Epigenetics and aging: status, challenges, and needs for the future, J. Gerontol. A Biol. Sci. Med. Sci., 64, 195, 10.1093/gerona/gln064

Wilson, 1983, DNA methylation decreases in aging but not in immortal cells, Science, 220, 1055, 10.1126/science.6844925

Turunen, 2009, Epigenetics and atherosclerosis, Biochim. Biophys. Acta, 1790, 886, 10.1016/j.bbagen.2009.02.008

Dong, 2002, DNA methylation and atherosclerosis, J. Nutr., 132, 2406S, 10.1093/jn/132.8.2406S

Hiltunen, 2003, DNA Methylation, smooth muscle cells, and atherogenesis, Arterioscler. Thromb. Vasc. Biol., 23, 1750, 10.1161/01.ATV.0000092871.30563.41

Burton, 2007, Cyclin D1 overexpression permits the reproducible detection of senescent human vascular smooth muscle cells, Ann. N. Y. Acad. Sci., 1119, 20, 10.1196/annals.1404.026

Karimi, 2011, Global DNA methylation analysis using the luminometric methylation assay, Methods Mol. Biol., 791, 135, 10.1007/978-1-61779-316-5_11

Fazzari, 2004, Epigenomics: beyond CpG islands, Nat. Rev. Genet., 5, 446, 10.1038/nrg1349

Misawa, 2005, Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification, Cancer Res., 65, 10233, 10.1158/0008-5472.CAN-05-1073

Fiegler, 2006, Accurate and reliable high-throughput detection of copy number variation in the human genome, Genome Res., 16, 1566, 10.1101/gr.5630906

Seo, 2004, Gene expression phenotypes of atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 24, 1922, 10.1161/01.ATV.0000141358.65242.1f

Won, 2009, Choosing an optimal method to combine P-values, Stat. Med., 28, 1537, 10.1002/sim.3569

Minear, 2011, Polymorphic variants in tenascin-C (TNC) are associated with atherosclerosis and coronary artery disease, Hum. Genet., 129, 641, 10.1007/s00439-011-0959-z

Myers, 2007, The molecular structure of human tissue type XV presents a unique conformation among the collagens, Biochem. J., 404, 535, 10.1042/BJ20070201

Wirz, Crystal structure of the human collagen XV trimerization domain: a potent trimerizing unit common to multiplexin collagens, Matrix Biol., 30, 9, 10.1016/j.matbio.2010.09.005

Li, 2000, Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells, J. Biol. Chem., 275, 22339, 10.1074/jbc.M000519200

Kivirikko, 1995, Distribution of type XV collagen transcripts in human tissue and their production by muscle cells and fibroblasts, Am. J. Pathol., 147, 1500

Amenta, 2005, Proteoglycan-collagen XV in human tissues is seen linking banded collagen fibers subjacent to the basement membrane, J. Histochem. Cytochem., 53, 165, 10.1369/jhc.4A6376.2005

Eklund, 2001, Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice, Proc. Natl Acad. Sci. USA, 98, 1194, 10.1073/pnas.98.3.1194

Ylikarppa, 2003, Double knockout mice reveal a lack of major functional compensation between collagens XV and XVIII, Matrix Biol., 22, 443, 10.1016/S0945-053X(03)00074-X

Rasi, 2010, Collagen XV is necessary for modeling of the extracellular matrix and its deficiency predisposes to cardiomyopathy, Circ. Res., 107, 1241, 10.1161/CIRCRESAHA.110.222133

Rasi, 2010, Lack of collagen XV impairs peripheral nerve maturation and, when combined with laminin-411 deficiency, leads to basement membrane abnormalities and sensorimotor dysfunction, J. Neurosci., 30, 14490, 10.1523/JNEUROSCI.2644-10.2010

Hurskainen, 2010, Recombinant human collagen XV regulates cell adhesion and migration, J. Biol. Chem., 285, 5258, 10.1074/jbc.M109.033787

John, 2005, Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin, Biochim. Biophys. Acta, 1747, 161, 10.1016/j.bbapap.2004.10.013

O'Reilly, 1997, Endostatin: an endogenous inhibitor of angiogenesis and tumor growth, Cell, 88, 277, 10.1016/S0092-8674(00)81848-6

Harris, 2007, Complete suppression of tumor formation by high levels of basement membrane collagen, Mol. Cancer Res., 5, 1241, 10.1158/1541-7786.MCR-07-0200

Ramchandran, 1999, Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin, Biochem. Biophys. Res. Commun., 255, 735, 10.1006/bbrc.1999.0248

Xu, 2002, Mouse restin inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis, Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), 34, 138

Schwartz, 2000, The good smooth muscle cells in atherosclerosis, Curr. Atheroscler. Rep., 2, 422, 10.1007/s11883-000-0081-5

Rudijanto, 2007, The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis, Acta Med. Indones., 39, 86

Klein, 2005, Clinical implications and mechanisms of plaque rupture in the acute coronary syndromes, Am. Heart Hosp. J., 3, 249, 10.1111/j.1541-9215.2005.03221.x

Adiguzel, 2009, Collagens in the progression and complications of atherosclerosis, Vasc. Med., 14, 73, 10.1177/1358863X08094801

Butcher, 2008, Future impact of integrated high-throughput methylome analyses on human health and disease, J. Genet. Genomics, 35, 391, 10.1016/S1673-8527(08)60057-0

Toyota, 1999, Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification, Cancer Res., 59, 2307

Cherepanova, 2009, Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration, Circ. Res., 104, 609, 10.1161/CIRCRESAHA.108.186064

Connelly, 2008, Genetic and functional association of FAM5C with myocardial infarction, BMC Med. Genet., 9, 33, 10.1186/1471-2350-9-33

Sutton, 2008, Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case–control and family datasets, Hum. Mol. Genet., 17, 1318, 10.1093/hmg/ddn020

de Bakker, 2005, Efficiency and power in genetic association studies, Nat. Genet., 37, 1217, 10.1038/ng1669

Abecasis, 2000, GOLD–graphical overview of linkage disequilibrium, Bioinformatics, 16, 182, 10.1093/bioinformatics/16.2.182